[Pharmacology of a new anti-angina preparation, nonachlazin].
Data on pharmacology of nonachlazine-a new antianginal preparation effective in the treatment of patients with ischemic heart disease-are presented. The drug tends to greatly improve the blood supply of the heart. Its beneficial action comes from the ability to intensively and protractedly enhance the coronary blood flow, thus increasing the oxygen reserve of the heart with the contractility of the myocardium rising without any substantial changes in the cardiac output and work.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D003214:Conditioning, Classical / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010528:Peristalsis / Q000187:drug effects; D010640:Phenothiazines / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D014586:USSR; D014655:Vascular Resistance / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D010276:Parasympatholytics; D010640:Phenothiazines; D010879:Piperazines
K farmakologii novogo antianginal'nogo preparata nonakhlazina